ArticleAutophagy2024

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.

Weihao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.